EUVIMEDEUVIMED entdecken
Open Access

Novel furo[2,3- d ]pyrimidine derivatives as PI3K/AKT dual inhibitors: design, synthesis, biological evaluation, and molecular dynamics simulation

M A M Abdel Reheim, Walid E Elgammal iD, Mahmoud S Bashandy, Mohammed I A Hamed, Asmaa M AboulMagd iD, Mona G Khalil, Amr M Abdou iD, Rasha A Hassan iD

RSC Medicinal Chemistry · 2025 · 16 (8) · 3714-3735

DOI: 10.1039/d5md00139k ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von M A M Abdel Reheim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Arish University Arish 45511 Egypt. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of furo[2,3- d ]pyrimidine derivatives were synthesized and evaluated for their antiproliferative activity. Compound 10b revealed potent anticancer activity with mean GI% above 100, and remarkable anticancer activity.

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Arish University Arish 45511 Egypt.
  • Chemistry Department, Faculty of Science, Al-Azhar University Nasr City Cairo Egypt.
  • Department of Organic and Medicinal Chemistry, Faculty of Pharmacy, Fayoum University Fayoum 63514 Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Nahda University Beni Suef Egypt.
  • Pharmacology and Toxicology Department, Faculty of Pharmacy, Modern University for technology and Information Cairo Egypt.
  • Department of Microbiology and Immunology, National Research Centre Dokki Giza 12622 Egypt amrkheir@yahoo.com.

ORCID-Profile: Walid E Elgammal, Asmaa M AboulMagd, Amr M Abdou, Rasha A Hassan

Zitieren

APA

Reheim, M. A. M. A., Elgammal, W. E., Bashandy, M. S., Hamed, M. I. A., AboulMagd, A. M., Khalil, M. G., Abdou, A. M., & Hassan, R. A. (2025). Novel furo[2,3- d ]pyrimidine derivatives as PI3K/AKT dual inhibitors: design, synthesis, biological evaluation, and molecular dynamics simulation. RSC Medicinal Chemistry, 16(8), 3714-3735. https://doi.org/10.1039/d5md00139k

Vancouver

Reheim MAMA, Elgammal WE, Bashandy MS, Hamed MIA, AboulMagd AM, Khalil MG, et al. Novel furo[2,3- d ]pyrimidine derivatives as PI3K/AKT dual inhibitors: design, synthesis, biological evaluation, and molecular dynamics simulation. RSC Medicinal Chemistry. 2025;16(8):3714-3735. doi:10.1039/d5md00139k

BibTeX
@article{Reheim2025,
  author = {Reheim, M A M Abdel and Elgammal, Walid E and Bashandy, Mahmoud S and Hamed, Mohammed I A and AboulMagd, Asmaa M and Khalil, Mona G and Abdou, Amr M and Hassan, Rasha A},
  title = {Novel furo[2,3- d ]pyrimidine derivatives as PI3K/AKT dual inhibitors: design, synthesis, biological evaluation, and molecular dynamics simulation},
  journal = {RSC Medicinal Chemistry},
  year = {2025},
  volume = {16},
  number = {8},
  pages = {3714--3735},
  doi = {10.1039/d5md00139k}
}
Kostenlos starten →